Biochips Market - A Global and Regional Analysis - Analysis and Forecast, 2024-2033

Description

The global biochip market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecast that a decision maker can take advantage of.

The market study encompasses a detailed examination of various applications including technological advancements, and market dynamics. It explores the market based on segmentations such as by application, by end user, and by product type and highlights the competitive landscape, profiling key players and their strategies for market expansion. The report delves into regional segmentation, evaluating market performance across different geographical areas. Additionally, it discusses the impact of macroeconomic factors on market growth and explores potential investment opportunities for stakeholders.

With a focus on fostering a deep understanding of market dynamics, the report serves as a valuable resource for businesses, investors, and industry participants seeking strategic insights into the evolving global biobanks market.

Market Segmentation:

Segmentation 1: by Technology

Microarrays
Microfluidics

Segmentation 2: by End User

Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Centers
Academic & Research Institutes
Others

Segmentation 3: by Type

DNA Chips
Lab-on-Chip
Protein Chips
Other Arrays

Segmentation 4: by Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Key Questions Answered:

What are the major market drivers, challenges and opportunities in the global biochips market and their case studies?
How the biochips market evolves and what did is its scope in the future?
What is the market share of the leading segments and sub-segments of the global biochips market?
How will each segment of the global biochips market grow during the forecast period?
What are the influencing factors that may affect the market share of the key players?
How will the industry evolve during the forecast period?
What are the key developmental strategies implemented by the key players to stand out in this market?

Product Code: BHP1695SA

Executive Summary

Scope and Definition

Market/Product Definition

Key Questions Answered

Analysis and Forecast Note

1. Markets: Industry Outlook

1.1. Trends: Current and Future Impact Assessment
1.2. Supply Chain Overview
- 1.2.1. Value chain Analysis
- 1.2.2. Market Map
- 1.2.3. Pricing Forecast
1.3. R&D Review
- 1.3.1. Patent Filing Trend by Country, by Company
1.4. Regulatory Landscape
1.5. Market Dynamics Overview
- 1.5.1. Market Drivers
- 1.5.2. Market Restraints
- 1.5.3. Market Opportunities

2. Biochip Market by Application

2.1. Application Segmentation
2.2. Application Summary
2.3. Global Biochip Market, by
- 2.3.1. DNA Chips
  - 2.3.1.1. Gene Expression
  - 2.3.1.2. SNP Genotyping
  - 2.3.1.3. Cancer Diagnosis & Treatment
  - 2.3.1.4. Genomics
  - 2.3.1.5. Drug Discovery
  - 2.3.1.6. Agricultural Biotechnology
  - 2.3.1.7. Other DNA Chip Applications
- 2.3.2. Lab-on-a-Chip Market
  - 2.3.2.1. Clinical Diagnostics
  - 2.3.2.2. Genomics
  - 2.3.2.3. IVD & POC
  - 2.3.2.4. Proteomics
  - 2.3.2.5. Drug Discovery
  - 2.3.2.6. Others
- 2.3.3. Protein Chips Market
  - 2.3.3.1. Proteomics
  - 2.3.3.2. Expression Profiling
  - 2.3.3.3. Diagnostics
  - 2.3.3.4. High-Throughput Screening
  - 2.3.3.5. Drug Discovery
- 2.3.4. Other Arrays
  - 2.3.4.1. Cell Arrays
  - 2.3.4.2. Tissue Arrays
2.4. By Technology
- 2.4.1. Microarrays
- 2.4.2. Microfluidics
2.5. By End User
- 2.5.1. Biotechnology and Pharmaceutical Companies
- 2.5.2. Hospitals and Diagnostic Centers
- 2.5.3. Academic & Research Institutes
- 2.5.4. Others

3. Biochip Market by Product

3.1. Product Segmentation
3.2. Product Summary
3.3. Global Biochip Market, by Type
- 3.3.1. DNA Chips
- 3.3.2. Lab-on-Chip
- 3.3.3. Protein Chips
- 3.3.4. Other Arrays

4. Biochip Market by Region

4.1. Regional Summary
4.2. Drivers and Restraints
4.3. North America
- 4.3.1. Markets
  - 4.3.1.1. Key Market Participants in North America
  - 4.3.1.2. Business Drivers
  - 4.3.1.3. Business Challenges
- 4.3.2. Application
- 4.3.3. Product
- 4.3.4. North America by Country
  - 4.3.4.1. U.S.
  - 4.3.4.2. Canada
4.4. Europe
- 4.4.1. Markets
  - 4.4.1.1. Key Market Participants in Europe
  - 4.4.1.2. Business Drivers
  - 4.4.1.3. Business Challenges
- 4.4.2. Application
- 4.4.3. Product
- 4.4.4. Europe by Country
  - 4.4.4.1. U.K.
  - 4.4.4.2. Germany
  - 4.4.4.3. France
  - 4.4.4.4. Italy
  - 4.4.4.5. Spain
  - 4.4.4.6. Rest of Europe
4.5. Asia-Pacific
- 4.5.1. Markets
  - 4.5.1.1. Key Market Participants in Asia-Pacific
  - 4.5.1.2. Business Drivers
  - 4.5.1.3. Business Challenges
- 4.5.2. Application
- 4.5.3. Product
- 4.5.4. Asia-Pacific by Country
  - 4.5.4.1. China
  - 4.5.4.2. Japan
  - 4.5.4.3. India
  - 4.5.4.4. South Korea
  - 4.5.4.5. Rest of Asia-Pacific
4.6. Latin America
- 4.6.1. Markets
  - 4.6.1.1. Key Market Participants in Latin America
  - 4.6.1.2. Business Drivers
  - 4.6.1.3. Business Challenges
- 4.6.2. Application
- 4.6.3. Product
- 4.6.4. Latin America by Country
  - 4.6.4.1. Brazil
  - 4.6.4.2. Mexico
  - 4.6.4.3. Rest of Latin America
4.7. Middle East and Africa
- 4.7.1. Markets
  - 4.7.1.1. Key Market Participants in Middle East and Africa
  - 4.7.1.2. Business Drivers
  - 4.7.1.3. Business Challenges
- 4.7.2. Application
- 4.7.3. Product

5. Markets - Competitive Landscape & Company Profiles

5.1. Competitive Landscape
5.2. Company Profiles
- 5.2.1. Thermo Fisher Scientific, Inc.
  - 5.2.1.1. Company Overview
  - 5.2.1.2. Top Products / Product Portfolio
  - 5.2.1.3. Top Competitors
  - 5.2.1.4. Target Customers /End-Users
  - 5.2.1.5. Key Personnel
  - 5.2.1.6. Market Share
  - 5.2.1.7. Analyst View
- 5.2.2. Agilent Technologies, Inc.
  - 5.2.2.1. Company Overview
  - 5.2.2.2. Top Products / Product Portfolio
  - 5.2.2.3. Top Competitors
  - 5.2.2.4. Target Customers /End-Users
  - 5.2.2.5. Key Personnel
  - 5.2.2.6. Market Share
  - 5.2.2.7. Analyst View
- 5.2.3. PerkinElmer Inc.
  - 5.2.3.1. Company Overview
  - 5.2.3.2. Top Products / Product Portfolio
  - 5.2.3.3. Top Competitors
  - 5.2.3.4. Target Customers /End-Users
  - 5.2.3.5. Key Personnel
  - 5.2.3.6. Market Share
  - 5.2.3.7. Analyst View
- 5.2.4. Illumina Inc.
  - 5.2.4.1. Company Overview
  - 5.2.4.2. Top Products / Product Portfolio
  - 5.2.4.3. Top Competitors
  - 5.2.4.4. Target Customers /End-Users
  - 5.2.4.5. Key Personnel
  - 5.2.4.6. Market Share
  - 5.2.4.7. Analyst View
- 5.2.5. Bio-Rad Laboratories, Inc.
  - 5.2.5.1. Company Overview
  - 5.2.5.2. Top Products / Product Portfolio
  - 5.2.5.3. Top Competitors
  - 5.2.5.4. Target Customers /End-Users
  - 5.2.5.5. Key Personnel
  - 5.2.5.6. Market Share
  - 5.2.5.7. Analyst View
- 5.2.6. Standard Bio Tools
  - 5.2.6.1. Company Overview
  - 5.2.6.2. Top Products / Product Portfolio
  - 5.2.6.3. Top Competitors
  - 5.2.6.4. Target Customers /End-Users
  - 5.2.6.5. Key Personnel
  - 5.2.6.6. Market Share
  - 5.2.6.7. Analyst View
- 5.2.7. GE Healthcare
  - 5.2.7.1. Company Overview
  - 5.2.7.2. Top Products / Product Portfolio
  - 5.2.7.3. Top Competitors
  - 5.2.7.4. Target Customers /End-Users
  - 5.2.7.5. Key Personnel
  - 5.2.7.6. Market Share
  - 5.2.7.7. Analyst View
- 5.2.8. Li-COR Inc.
  - 5.2.8.1. Company Overview
  - 5.2.8.2. Top Products / Product Portfolio
  - 5.2.8.3. Top Competitors
  - 5.2.8.4. Target Customers /End-Users
  - 5.2.8.5. Key Personnel
  - 5.2.8.6. Market Share
  - 5.2.8.7. Analyst View
- 5.2.9. Qiagen
  - 5.2.9.1. Company Overview
  - 5.2.9.2. Top Products / Product Portfolio
  - 5.2.9.3. Top Competitors
  - 5.2.9.4. Target Customers /End-Users
  - 5.2.9.5. Key Personnel
  - 5.2.9.6. Market Share
  - 5.2.9.7. Analyst View
- 5.2.10. Randox Laboratories Ltd
  - 5.2.10.1. Company Overview
  - 5.2.10.2. Top Products / Product Portfolio
  - 5.2.10.3. Top Competitors
  - 5.2.10.4. Target Customers /End-Users
  - 5.2.10.5. Key Personnel
  - 5.2.10.6. Market Share
  - 5.2.10.7. Analyst View